Coronavirus Vaccine Tracker | Covaxine Covishield Zydus Cadila | Who Will Get First Coronavirus Vaccine In India | What are the Difficulties Government is Facing in Distribution and Delivery of Coronavirus Covid-19 | When will we get the vaccine in India, who will get it first and will it be free? » India News
Connect with us

India News

Coronavirus Vaccine Tracker | Covaxine Covishield Zydus Cadila | Who Will Get First Coronavirus Vaccine In India | What are the Difficulties Government is Facing in Distribution and Delivery of Coronavirus Covid-19 | When will we get the vaccine in India, who will get it first and will it be free?

Published

on

  • Hindi news
  • Db original
  • Explainer
  • Coronavirus Vaccine Tracker | Covaxine Covishield Zydus Cadila | Who Will Get First Coronavirus Vaccine In India | What Are The Difficulties Government Is Facing In Distribution And Delivery Of Coronavirus Covid 19

19 minutes ago

  • Copy link

The number of corona patients in the country has crossed 81 lakhs. It is a matter of relief that 74.30 lakh people have recovered, that is, more than 90% recovery rate. Active cases are also decreasing. Even then, doctors and experts are not ruling out the possibility of a second wave of corona in winter. In such a situation, the vaccine is waiting eagerly, which is necessary to completely eliminate the corona. How long will the vaccine be available in India? Who will get it first and will it be free? Let’s know what are the answers to such questions so far …

What is the government’s plan to distribute the corona vaccine?

  • At this time, no vaccine has been approved as safe and effective. Even after this, the central government has started work on the delivery plan of the vaccine. So that they get the vaccine first, who need it the most. For this, the Central Government’s Special Task Force has also asked the states to make their own lists, which can be given vaccines on priority.

What is the priority basis? Who will get the vaccine first?

  • As soon as the vaccine is approved, its number will not be such that everyone can get the vaccine in the whole country. Because of which the vaccine will be given first, many factors will be seen for this. It will also be seen how many vaccines are available in the first stage. What would be the situation if only one vaccine was licensed? If four are licensed, the situation will be different.
  • It has been agreed worldwide that who should be given priority in the vaccine. Since the vaccine will be limited initially, the vaccine will be first made available to health and epidemic control systems. Along with frontline health workers, security personnel, police, municipal employees, drivers etc. will also be given priority.
  • The Health Ministry has asked the states to form a co-ordination committee. The center said that the process of applying vaccine to different groups could go on for a year. Which will start with healthcare workers. Because of this, co-ordination at the state and district level is very important.

Will this vaccine be free in India?

  • In Bihar, in its election manifesto, the BJP promised to get the vaccine free if it wins the elections. There was a ruckus on this and the Central Government had to clear that the vaccine would be made available to all for free. But, so far nothing is clear.
  • Actually, it will be decided on which and how many vaccines are licensed. Central officials have also presented an estimated budget for this, but nothing has been decided so far. The government will ensure that there is no shortage of money in making the vaccine available to all.
  • It seems that people will need more than a dose in the initial phase. Assuming that two doses will be given with a difference of 28 days. Accordingly its cost will be fixed. How many vaccines are licensed, this factor will also be important.

Which vaccine will be available first?

  • Nothing is clear at this time. The claims have come out differently. Two indigenous vaccines in India, Bharat Biotech’s Kovaxin and Zydus Cadila vaccine are also in Phase-3 trials. In addition, Oxford-AstraZeneca’s Coveshield is also in Phase-3 trials.
  • CEO of Serum Institute of India, which has been licensed to produce CoveShield in India, Adar Poonawala, CEO, said that production of CoveShield will begin by December. He says that this vaccine will be available in India next year.
  • Poonawala says that 10 crore doses will be available by the second quarter of 2021. If the emergency license is not obtained, the trials will be completed by December. The vaccine will be launched in India in January. The UK trial is also nearing completion.
  • But, these are all claims. Until a vaccine is licensed, it is extremely difficult to determine or estimate any date. The second is to create a network of cold chains even after the approval of the vaccine to reach the center and place it. The government has started work on this too.
  • The preparations made in India include the use of digital technology. People have to come to the booth only when they are called. By sending an SMS, people will be told when and where to come for the vaccine.

What is the problem in getting the vaccine to the booth?

  • After the vaccine is created, the biggest challenge will be storage, distribution and delivery. There are 25 thousand cold stores to store the vaccine in India, where there is storage in 4 ° C. If such a vaccine is approved, which needs to be kept in the fridge, then it can be a problem.
  • Second, logistics is also a big issue. The Russian vaccine SPUTNIK V will have to be stored at -80 ° C if approved. This will also change the logistic needs. The manufacturing facility may have difficulty reaching the delivery point.
  • The serum institute that is producing the coveshield has to be kept at 10–20 ° C, for which a cold store can be used. Because of this, it is believed that after availability it can be used easily.

Advertisement

bareilly